“Marc Beer Joins Forces with Boston Women’s Health to Provide Innovate Pelvic Relief “

In 1987 Marc Beer walked out of the University of Miami with a Bachelor’s of Science Degree and he never looked back. Instead, he focused on biotechnology, pharmaceuticals, devices, and diagnostics with a specialization in developing these further and commercializing them so the consumer understood how it would make both their lives and the lives of their children better.

One of his biggest accomplishments includes becoming the founding CEO of ViaCell, which specializes in preserving stem cells from umbilical cords. He not only kept the company growing but made it thrive.

And now he’s using his company Renovia Inc. to help the pelvic floor at Boston Women’s Health. This plan cost about thirty-two million dollars in Series B along with ten million in venture debt. The exciting thing about this venture with Boston Women’s Health is that the money will be spent with the goal to improve the lives of women in the community who struggle with silent disorders. With the money, they are developing both diagnostic and therapeutic products to help people with issues such as urinary incontinence. Urinary incontinence is a problem that affects two hundred and fifty million women worldwide. The venture’s first product received FDA approval in April, giving women who are already in Boston Women’s some relief already.

Several companies saw and believed in what Renovia Inc. was doing and backed them up. These companies include the Longwood Firm, New York’s Perceptive Advisors, and Missouri’s Ascension Ventures. Their funding will help further the goal of relief by testing out four more diagnostic and therapeutic products, including a new generation of the Leva device.

The Leva device is a digital health program that uses Bluetooth to give interactive visualization to women, giving them real-time progress tracking, helping them strengthen and rehabilitate weak pelvic muscles. It does this without surgery or medicine.

Marc Beer stated that the goal for the funding and devices is to, “give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders, and ultimately lower long-term healthcare costs.” Something, it seems, everyone can get behind. Learn more: https://www.slideshare.net/MarcBeer

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *